Compare AAPG & TOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AAPG | TOP |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | China | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2024 | 2021 |
| Metric | AAPG | TOP |
|---|---|---|
| Price | $16.00 | $15.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $48.40 | N/A |
| AVG Volume (30 Days) | 5.8K | ★ 111.3K |
| Earning Date | 05-20-2026 | 01-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.25 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,723,765.00 |
| Revenue This Year | $290.34 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 41.89 |
| 52 Week Low | $16.03 | $0.61 |
| 52 Week High | $40.47 | $17.42 |
| Indicator | AAPG | TOP |
|---|---|---|
| Relative Strength Index (RSI) | 41.95 | 63.14 |
| Support Level | N/A | $14.34 |
| Resistance Level | $18.45 | $17.42 |
| Average True Range (ATR) | 0.35 | 1.29 |
| MACD | -0.08 | -0.47 |
| Stochastic Oscillator | 14.07 | 17.67 |
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.
TOP Financial Group Ltd is operates as an online brokerage firm in Hong Kong specializing in the trading of local and overseas equities, futures, and options products. It conduct the futures and stock brokerage business through three trading platforms, Esunny for futures trading and Longbridge for stock trading, all of which were licensed from third parties and can be easily accessed through its application, or APP, software, and websites. The three platforms are designed for seamless, efficient, and secure trading platform. The company operates and manages its business as a single operating and reportable segment.